Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert Daniel Rosenberg, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Robert Rosenberg and Keiichi Enjyoji.
Connection Strength

0.291
  1. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med. 1999 Sep; 5(9):1010-7.
    View in: PubMed
    Score: 0.215
  2. Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer. Purinergic Signal. 2011 Jun; 7(2):231-41.
    View in: PubMed
    Score: 0.030
  3. Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis. J Clin Invest. 2003 Apr; 111(7):989-99.
    View in: PubMed
    Score: 0.017
  4. CD39/vascular ATP diphosphohydrolase modulates xenograft survival. Transplant Proc. 2000 Aug; 32(5):969.
    View in: PubMed
    Score: 0.014
  5. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection. Mol Med. 1999 Nov; 5(11):743-52.
    View in: PubMed
    Score: 0.014
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.